RESUMO
BACKGROUND: Information on gestational surrogacy arrangement and outcomes is limited in Australia. AIMS: This national population study investigates the epidemiology of gestational surrogacy arrangement in Australia: treatment procedures, pregnancy and birth outcomes. MATERIALS AND METHODS: A retrospective study was conducted of 169 intended parents cycles and 388 gestational carrier cycles in Australia in 2004-2011. Demographics were compared between intended parents and gestational carrier cycles. Pregnancy and birth outcomes were compared by number of embryos transferred. RESULTS: Over half (54%) intended parents cycles were in women aged <35 years compared to 38% of gestational carrier cycles. About 77% of intended parents cycles were of nulliparous women compared to 29% of gestational carrier cycles. Of the 360 embryo transfer cycles, 91% had cryopreserved embryos transferred and 69% were single-embryo transfer (SET) cycles. The rates of clinical pregnancy and live delivery were 26% and 19%, respectively. There were no differences in rates of clinical pregnancy and live delivery between SET cycles (27% and 19%) and double-embryo transfer (DET) cycles (25% and 19%). Five of 22 deliveries following DET were twin deliveries compared to none of 48 deliveries following SET. There were 73 liveborn babies following gestational surrogacy treatment, including 9 liveborn twins. Of these, 22% (16) were preterm and 14% (10) were low birthweight. Preterm birth was 13% for liveborn babies following SET, lower than the 31% or liveborn babies following DET. CONCLUSIONS: To avoid adverse outcomes for both carriers and babies, SET should be advocated in all gestational surrogacy arrangements.
Assuntos
Criopreservação , Embrião de Mamíferos , Nascido Vivo , Resultado da Gravidez , Transferência de Embrião Único/estatística & dados numéricos , Mães Substitutas/estatística & dados numéricos , Adulto , Austrália/epidemiologia , Feminino , Humanos , Recém-Nascido de Baixo Peso , Recém-Nascido , Pessoa de Meia-Idade , Paridade , Gravidez , Gravidez de Gêmeos/estatística & dados numéricos , Nascimento Prematuro/epidemiologia , Estudos Retrospectivos , Adulto JovemRESUMO
This article provides an overview of cross-border reproductive care from a patient perspective. It outlines motives for seeking reproductive care outside patients' home countries or in other jurisdictions of their home country, describes the role of patients' organizations in general, and concludes by indicating potentials for collaboration between professionals' and patients' organizations.
Assuntos
Associações de Consumidores/normas , Satisfação do Paciente , Qualidade da Assistência à Saúde/normas , Técnicas de Reprodução Assistida/normas , Associações de Consumidores/legislação & jurisprudência , Feminino , Humanos , Internacionalidade , Masculino , Programas Nacionais de Saúde/normas , Satisfação do Paciente/legislação & jurisprudência , Qualidade da Assistência à Saúde/legislação & jurisprudência , Técnicas de Reprodução Assistida/legislação & jurisprudênciaAssuntos
Técnicas de Reprodução Assistida , Austrália , Ética Clínica , Fertilização in vitro/economia , Fertilização in vitro/ética , Fertilização in vitro/estatística & dados numéricos , Governo , Humanos , Assistência Médica , Técnicas de Reprodução Assistida/economia , Técnicas de Reprodução Assistida/ética , Técnicas de Reprodução Assistida/legislação & jurisprudênciaRESUMO
This paper reports the proceedings of a consensus meeting on the incidence and complications of multiple gestation in Canada. In addition to background presentations about current and possible future practice in Canada, the expert panel also developed a set of consensus points. The need for infertility to be understood, and funded, as a healthcare problem was emphasized, along with recognition of the emotional impact of infertility. It was agreed that the goal of assisted reproduction treatment is the delivery of a single healthy infant and that even though many positive outcomes have resulted from twin or even triplet pregnancies, the potential risks associated with multiple pregnancy require that every effort be made to achieve this goal. The evidence shows that treatments other than IVF (such as superovulation and clomiphene citrate) contribute significantly to the incidence of multiple pregnancy. There is an urgent need for studies to understand better the usage and application of these other fertility technologies within Canada, as well as the non-financial barriers to treatment. The final consensus of the expert panel was that with adequate funding and good access to treatment, it will be possible to achieve the goal of reducing IVF-related multiple pregnancy rates in Canada by 50%.